A Prospective, Randomized, Active Controlled, Parallel Group, Multi-center Trial to Assess the Efficacy and Safety of Mycophenolate Mofetil (MMF) in Inducing Response and Maintaining Remission in Subjects With Lupus Nephritis.

Trial Profile

A Prospective, Randomized, Active Controlled, Parallel Group, Multi-center Trial to Assess the Efficacy and Safety of Mycophenolate Mofetil (MMF) in Inducing Response and Maintaining Remission in Subjects With Lupus Nephritis.

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Nov 2011

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Azathioprine; Cyclophosphamide
  • Indications Lupus nephritis
  • Focus Registrational; Therapeutic Use
  • Acronyms ALMS
  • Sponsors Roche
  • Most Recent Events

    • 16 Jul 2010 Status changed from recruiting to completed as reported by Roche.
    • 29 Jun 2010 Further top-line results from the maintenance phase of this trial have been reported in a Vifor Pharma media release.
    • 03 Jun 2010 Results from the maintenance phase of this trial will be presented at the 9th International Congress on SLE in June 2010, according to a Vifor Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top